| 000 | 01167 a2200325 4500 | ||
|---|---|---|---|
| 005 | 20250513040430.0 | ||
| 264 | 0 | _c19930914 | |
| 008 | 199309s 0 0 eng d | ||
| 022 | _a0025-6196 | ||
| 024 | 7 |
_a10.1016/s0025-6196(12)60603-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMonda, J M | |
| 245 | 0 | 0 |
_aMedical treatment of benign prostatic hyperplasia: 5 alpha-reductase inhibitors and alpha-adrenergic antagonists. _h[electronic resource] |
| 260 |
_bMayo Clinic proceedings _cJul 1993 |
||
| 300 |
_a670-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _a5-alpha Reductase Inhibitors |
| 650 | 0 | 4 |
_aAdrenergic alpha-Antagonists _xadverse effects |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAndrostenes _xadverse effects |
| 650 | 0 | 4 |
_aAzasteroids _xadverse effects |
| 650 | 0 | 4 | _aFinasteride |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aProstatic Hyperplasia _xdrug therapy |
| 700 | 1 | _aOesterling, J E | |
| 773 | 0 |
_tMayo Clinic proceedings _gvol. 68 _gno. 7 _gp. 670-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0025-6196(12)60603-x _zAvailable from publisher's website |
| 999 |
_c7688263 _d7688263 |
||